Increased local angiotensin II formation in aneurysmal aorta

Life sciences

Volumn 71, Issue 18, 2002, Pages 2195-2205

  Nishimoto, Masayoshi ^a,b   Takai, Shinji ^a   Fukumoto, Hitoshi ^b   Tsunemi, Koutaro ^a   Yuda, Atsushi ^a,b   Sawada, Yoshihide ^a   Yamada, Mayumi ^a,b   Jin, Denan ^a,b   Sakaguchi, Masato ^a,b   Nishimoto, Yasuhisa ^b   Sasaki, Shinjiro ^a   Miyazaki, Mizuo ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b Osaka Mishima Critical Care Medical Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; CHYMASE; DIPEPTIDYL CARBOXYPEPTIDASE; SERINE PROTEINASE;

AGED; AORTA; AORTA ANEURYSM; ARTICLE; BIOSYNTHESIS; ENZYMOLOGY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; METABOLISM; MIDDLE AGED;

AGED; AGED, 80 AND OVER; ANGIOTENSIN II; AORTA; AORTIC ANEURYSM; CHYMASES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; SERINE ENDOPEPTIDASES;

EID: 19044382607     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(02)01998-7     Document Type: Article

References (49)

1. J.J. Grange V. Davis B.T. Baxter Pathogenesis of abdominal aortic aneurysm: an update and look toward the future Cardiovascular Surgery 5 3 1997 256 265
2. R.W. Thompson Basic science of abdominal aortic aneurysms: emerging therapeutic strategies for an unresolved clinical problem Current Opinion in Cardiology 11 5 1996 504 514
3. A. Delin H. Ohlsen J. Swedenborg Growth rate of abdominal aortic aneurysms as measured by computed tomography British Journal of Surgery 72 7 1985 530 532
4. A.V. Sterpetti R.D. Schultz R.J. Feldhaus S.E. Cheng D.J. Peetz Jr. Factors influencing enlargement rate of small abdominal aortic aneurysms Journal of Surgical Research 43 3 1987 211 219
5. M.P. Nevitt D.J. Ballard J.W. Hallett Jr. Prognosis of abdominal aortic aneurysms New England Journal of Medicine 321 15 1989 1009 1014
6. J.V. White K. Haas S. Phillips A.J. Comerota Adventitial elastolysis is a primary event in aneurysm formation Journal of Vascular Surgery 17 2 1993 371 381
7. A.J. Naftilan G. Gilliland C.S. Eldridge A.S. Kraft Induction of the proto-oncogene c-jun by angiotensin II Molecular and Cellular Biology 10 10 1990 5536 5540
8. H. Schelling H. Fischer D. Ganten Angiotensin and cell growth: a link to cardiovascular hypertrophy? Journal of Hypertension 9 1 1991 3 15
9. S. Keidar M. Kaplan A. Hoffman M. Aviram Angiotensin II stimulates macrophage-mediated oxidation of low density lipoproteins Atherosclerosis 115 2 1995 201 215
10. K.J. Scheidegger S. Butler J.L. Witztum Angiotensin II increases macrophage-mediated modification of low density lipoprotein via a lipoxygenase-dependent pathway Journal of Biological Chemistry 272 34 1997 21609 21615
11. H. Morawietz U. Rueckschloss B. Niemann N. Duerrschmidt J. Galle K. Hakim H.R. Zerkowski T. Sawamura J. Holtz Angiotensin II induces LOX-1, the human endothelial receptor for oxidized low-density lipoprotein Circulation 100 9 1999 899 902
12. S. Matsumoto T. Kobayashi M. Katoh S. Saito Y. Ikeda M. Kobori Y. Masuho T. Watanabe Expression and localization of matrix metalloproteinase-12 in the aorta of cholesterol-fed rabbits: relationship to lesion development American Journal of Pathology 153 1 1998 109 119
13. S. Rajagopalan X.P. Meng S. Ramasamy D.G. Harrison Z.S. Galis Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability Journal of Clinical Investigation 98 11 1996 2572 2579
14. Z.S. Galis G.K. Sukhova M.W. Lark P. Libby Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques Journal of Clinical Investigation 94 6 1994 2493 2503
15. A.V. Chobanian A.H. Lichtenstein V. Nilakhe C.C. Haudenschild R. Drago C. Nickerson Influence of hypertension on aortic atherosclerosis in the Watanabe rabbit Hypertension 14 2 1989 203 209
16. J.H. Campbell P. Fennessy G.R. Campbell Effect of perindopril on the development of atherosclerosis in the cholesterol-fed rabbit Clinical Experimental Pharmacology and Physiology 19 1992 13 17 (Supplement)
17. P.A. Fennessy J.H. Campbell F.A. Mendelsohn G.R. Campbell Angiotensin-converting enzyme inhibitors and atherosclerosis: relevance of animal models to human disease Clinical Experimental Pharmacology and Physiology 23 1996 S30 S32 (Supplement)
18. M. Miyazaki S. Takai Antiatherosclerotic effect of alacepril, an angiotensin-converting enzyme inhibitor, in monkeys fed a high-cholesterol diet Hypertension Research 22 1 1999 49 54
19. M. Miyazaki H. Sakonjo S. Takai Anti-atherosclerotic effects of an angiotensin converting enzyme inhibitor and an angiotensin II antagonist in Cynomolgus monkeys fed a high-cholesterol diet British Journal of Pharmacology 128 3 1999 523 529
20. W.B. Strawn M.C. Chappell R.H. Dean S. Kivlighn C.M. Ferrario Inhibition of early atherogenesis by losartan in monkeys with diet-induced hypercholesterolemia Circulation 101 13 2000 1586 1593
21. S. Takai N. Shiota M. Sakaguchi H. Muraguchi E. Matsumura M. Miyazaki Characterization of chymase from human vascular tissues Clinica Chimica Acta 265 1 1997 13 20
22. S. Takai D. Jin M. Sakaguchi M. Miyazaki Chymase-dependent angiotensin II formation in human vascular tissue Circulation 100 6 1999 654 658
23. S. Takai A. Yuda D. Jin M. Nishimoto M. Sakagichi S. Sasaki M. Miyazaki Inhibition of chymase reduces vascular proliferation in dog grafted veins FEBS Letters 467 2–3 2000 141 144
24. P. Laine M. Kaartinen A. Penttila P. Panula T. Paavonen P.T. Kovanen Association between myocardial infarction and the mast cells in the adventitia of the infarct-related coronary artery Circulation 99 3 1999 361 369
25. P. Laine A. Naukkarinen L. Heikkila A. Penttila P.T. Kovanen Adventitial mast cells connect with sensory nerve fibers in atherosclerotic coronary arteries Circulation 101 14 2000 1665 1669
26. K.J. Scheidegger S. Butler J.L. Witztum Angiotensin II increases macrophage-mediated modification of low density lipoprotein via a lipoxygenase-dependent pathway Journal of Biological Chemistry 272 34 1997 21609 21615
27. A. Warnholtz G. Nickenig E. Schulz R. Macharzina J.H. Brasen M. Skatchkov T. Heitzer J.P. Stasch K.K. Griendling D.G. Harrison M. Bohm T. Meinertz T. Munzel Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin–angiotensin system Circulation 99 15 1999 2027 2033
28. S. Keidar Angiotensin, LDL peroxidation and atherosclerosis Life Sciences 63 1 1998 1 11
29. M. Kaartinen A. Penttila P.T. Kovanen Mast cells of two types differing in neutral protease composition in the human aortic intima. Demonstration of tryptase- and tryptase/chymase-containing mast cells in normal intimas, fatty streaks, and the shoulder region of atheromas Arteriosclerosis and Thrombosis 14 1994 966 972
30. M. Ohishi M. Ueda H. Rakugi T. Naruko A. Kojima A. Okamura J. Higaki T. Ogihara Enhanced expression of angiotensin-converting enzyme is associated with progression of coronary atherosclerosis in humans Journal of Hypertension 15 11 1997 1295 1302
31. M. Ohishi M. Ueda H. Rakugi A. Okamura T. Naruko A.E. Becker K. Hiwada A. Kamitani K. Kamide J. Higaki T. Ogihara Upregulation of angiotensin-converting enzyme during the healing process after injury at the site of percutaneous transluminal coronary angioplasty in humans Circulation 96 10 1997 3328 3337
32. K.S. Cross M.N. Sanadiki J.J. Murray E.M. Mikat R.L. McCann P.O. Hagen Mast cell infiltration: a possible mechanism for vein graft vasospasm Surgery 104 2 1988 171 177
33. M. Miyazaki N. Shiota H. Sakonjo S. Takai Angiotensin II type 1 receptor antagonist, TCV-116, prevents neointima formation in injured arteries in the dog Japanese Journal of Pharmacology 79 4 1999 455 460
34. A. Yuda S. Takai D. Jin Y. Sawada M. Nishimoto N. Matsuyama K. Asada K. Kondo S. Sasaki M. Miyazaki Angiotensin II receptor antagonist, L-158,809, prevents intimal hyperplasia in dog grafted veins Life Sciences 68 1 2000 41 48
35. M. Hernandez-Presa C. Bustos M. Ortego J. Tunon G. Renedo M. Ruiz-Ortega J. Egido Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis Circulation 95 6 1997 1532 1541
36. B. Schieffer E. Schieffer D. Hilfiker-Kleiner A. Hilfiker P.T. Kovanen M. Kaartinen J. Nussberger W. Harringer H. Drexler Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability Circulation 101 12 2000 1372 1378
37. A. Okamura H. Rakugi M. Ohishi Y. Yanagitani S. Takiuchi K. Moriguchi P.A. Fennessy J. Higaki T. Ogihara Upregulation of renin–angiotensin system during differentiation of monocytes to macrophages Journal of Hypertension 17 4 1999 537 545
38. T. Collins M.A. Read A.S. Neish M.Z. Whitley D. Thanos T. Maniatis Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers FASEB Journal 9 10 1995 899 909
39. M. Hernandez-Presa C. Bustos M. Ortego J. Tunon G. Renedo M. Ruiz-Ortega J. Egido Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis Circulation 5 6 1997 1532 1541
40. T. Mabuchi K. Kitagawa T. Ohtsuki K. Kuwabara Y. Yagita T. Yanagihara M. Hori M. Matsumoto Contribution of microglia/macrophages to expansion of infarction and response of oligodendrocytes after focal cerebral ischemia in rats Stroke 31 7 2000 1735 1743
41. X.L. Chen P.E. Tummala M.T. Olbrych R.W. Alexander R.M. Medford Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells Circulation Research 83 9 1998 952 959
42. S. Kato V.A. Luyckx M. Ots K.W. Lee F. Ziai J.L. Troy B.M. Brenner H.S. MacKenzie Renin–angiotensin blockade lowers MCP-1 expression in diabetic rats Kidney International 56 3 1999 1037 1048
43. K.F. Hilgers A. Hartner M. Porst M. Mai M. Wittmann C. Hugo D. Ganten H. Geiger R. Veelken J.F. Mann Monocyte chemoattractant protein-1 and macrophage infiltration in hypertensive kidney injury Kidney International 58 6 2000 2408 2419
44. A. Daugherty M.W. Manning L.A. Cassis Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice Journal of Clinical Investigation 105 11 2000 1605 1612
45. S. Liao M. Miralles B.J. Kelley J.A. Curci M. Borhani R.W. Thompson Suppression of experimental abdominal aortic aneurysms in the rat by treatment with angiotensin-converting enzyme inhibitors Journal of Vascular Surgery 33 5 2001 1057 1064
46. D.D. Metcalfe Mast cell mediators with emphasis on intestinal mast cells Annals of Allergy 53 6 1984 563 575
47. B.F. Ramos Y. Zhang B.A. Jakschik R. Qureshi Mast cells are critical for the production of leukotrienes responsible for neutrophils recruitment in immune complex-induced peritonitis in mice Journal of Immunology 147 5 1991 1636 1641
48. J. Saarinen N. Kalkkinen H.G. Welgus P.T. Kovanen Activation of human interstitial procollagenase through direct cleavage of Leu83–Thr84 bond by mast cell chymase Journal of Biological Chemistry 269 27 1994 18134 18140
49. B.T. Frank J.C. Rossall G.H. Caughey K.C. Fang Mast cell tissue inhibitor of metalloproteinase-1 is cleaved and inactivated extracellularly by alpha-chymase Journal of Immunology 166 4 2001 2783 2792